Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...

Shares in Moderna and BioNTech have imploded since their 2021 peaks, shaving billions of dollars from their founders’ ...

Moderna, Inc. (NASDAQ:MRNA) ranks among the best biotech stocks to buy. Following solid trial results for Moderna, Inc. (NASDAQ:MRNA)’s refrigerator-stable COVID-19 vaccine, Brookline Capital Markets ...

Many potential applications of automation tools face data protection hurdles. At the FutureHealth conference series, ...

In today’s high-cost R&D environment, pharma success depends less on cost-cutting and more on evidence-based portfolio decisions, niche-buster strategies, and real-world data-driven indication ...

US stocks steady as Fed rate cut bets grow following weak ADP data; Dow and S&P500 lift while shutdown risks take a back seat in trader focus today.

Moderately bullish activity in Moderna (MRNA), with shares up 18c, or 0.65%, near $28.55. Options volume roughly in line with average with 32k ...

How is SPY stock faring? The SPDR S&P 500 ETF Trust ($SPY) is up 0.83% over the past five days and has gained about 15.05% year-to-date. According ...

Among megacap stocks, Nvidia dropped 0.9%, Meta Platforms shed 2.8%, and Alphabet lost 1.1%. Healthcare stocks gained with ...

As the weather begins to change and respiratory illnesses become more common, a highly transmissible strain of COVID-19 is on ...

As CEOs and boards look for every possible edge in a world where technology is rapidly democratized, it will be people who ...

A substantial body of evidence supports the safety of the COVID-19 vaccines during pregnancy, contrary to the suggestions of ...